Related references
Note: Only part of the references are listed.α-Synuclein Transgenic Mice Reveal Compensatory Increases in Parkinson's Disease-Associated Proteins DJ-1 and Parkin and Have Enhanced α-Synuclein and PINK1 Levels After Rotenone Treatment
Sonia George et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging study
Vesna Sossi et al.
JOURNAL OF NEUROCHEMISTRY (2009)
A highly reproducible rotenone model of Parkinson's disease
Jason R. Cannon et al.
NEUROBIOLOGY OF DISEASE (2009)
Parkin Deficiency Delays Motor Decline and Disease Manifestation in a Mouse Model of Synucleinopathy
Margot Fournier et al.
PLOS ONE (2009)
Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice
Min Jeong Kang et al.
TOXICOLOGY LETTERS (2009)
Modeling PD pathogenesis in mice: Advantages of a chronic MPTP protocol
Gloria E. Meredith et al.
PARKINSONISM & RELATED DISORDERS (2008)
Dopamine transporter relation to dopamine turnover in Parkinson's disease:: A positron emission tomography study
Vesna Sossi et al.
ANNALS OF NEUROLOGY (2007)
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1
Laure Sonnier et al.
JOURNAL OF NEUROSCIENCE (2007)
Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice
Paola Sgadò et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys
Christian Pifl et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Behavioral models of Parkinson's disease in rodents: A new look at an old problem
Gloria E. Meredith et al.
MOVEMENT DISORDERS (2006)
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation
JR Adams et al.
BRAIN (2005)
Clinical and positron emission tomography of Parkinson's disease caused by LRRK2
DG Hernandez et al.
ANNALS OF NEUROLOGY (2005)
Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons
L Albéri et al.
DEVELOPMENT (2004)
Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone
SM Fleming et al.
EXPERIMENTAL NEUROLOGY (2004)
Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human Cu/Zn superoxide dismutase (Gly(93)-> Ala) mutation
R Geracitano et al.
NEUROSCIENCE (2003)
Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
JL Tillerson et al.
EXPERIMENTAL NEUROLOGY (2002)
Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism
BP Bergstrom et al.
JOURNAL OF NEUROSCIENCE METHODS (2001)
Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse
E Bezard et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Share Paper
